Advertisement
UK markets close in 7 hours 22 minutes
  • FTSE 100

    8,076.52
    +36.14 (+0.45%)
     
  • FTSE 250

    19,620.97
    -98.40 (-0.50%)
     
  • AIM

    754.09
    -0.60 (-0.08%)
     
  • GBP/EUR

    1.1661
    +0.0016 (+0.14%)
     
  • GBP/USD

    1.2513
    +0.0050 (+0.40%)
     
  • Bitcoin GBP

    51,162.28
    -2,178.73 (-4.08%)
     
  • CMC Crypto 200

    1,332.75
    -49.83 (-3.61%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.11
    +0.30 (+0.36%)
     
  • GOLD FUTURES

    2,337.60
    -0.80 (-0.03%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,264.06
    +62.79 (+0.37%)
     
  • DAX

    18,023.98
    -64.72 (-0.36%)
     
  • CAC 40

    8,075.71
    -16.15 (-0.20%)
     

Jazz Pharmaceuticals: How It’s Positioned before 1Q18

Jazz Pharmaceuticals: How It’s Positioned before 1Q18

In 4Q17, Jazz Pharmaceuticals (JAZZ) generated revenues of $436.4 million compared to $396.6 in 4Q16, which reflected a 10% growth on a YoY (year-over-year) basis and a 6% growth quarter-over-quarter.